Lung Stem and Progenitor Cells in Tissue Homeostasis and Disease

Kristen T. Leeman; Christine M. Fillmore; Carla F. Kim

doi:10.1016/B978-0-12-416022-4.00008-1

Lung Stem and Progenitor Cells in Tissue Homeostasis and Disease

Kristen T. Leeman, Christine M. Fillmore, Carla F. Kim

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

65 Scopus citations

Abstract

The mammalian lung is a complex organ containing numerous putative stem/progenitor cell populations that contribute to region-specific tissue homeostasis and repair. In this review, we discuss recent advances in identifying and studying these cell populations in the context of lung homeostasis and disease. Genetically engineered mice now allow for lineage tracing of several lung stem and progenitor cell populations in vivo during different types of lung injury repair. Using specific sets of cell surface markers, these cells can also be isolated from murine and human lung and tested in 3D culture systems and in vivo transplant assays. The pathology of devastating lung diseases, including lung cancers, is likely in part due to dysregulation and dysfunction of lung stem cells. More precise characterization of stem cells with identification of new, unique markers; improvement in isolation and transplant techniques; and further development of functional assays will ultimately lead to new therapies for a host of human lung diseases. In particular, lung cancer biology may be greatly informed by findings in normal lung stem cell biology as evidence suggests that lung cancer is a disease that begins in, and may be driven by, neoplastic lung stem cells.

Original language	English
Title of host publication	Current Topics in Developmental Biology
Pages	207-233
Number of pages	27
DOIs	https://doi.org/10.1016/B978-0-12-416022-4.00008-1
State	Published - 2014

Publication series

Name	Current Topics in Developmental Biology
Volume	107
ISSN (Print)	0070-2153

Bibliographical note

Funding Information:
We thank members of our laboratory for their discussions and critical comments on the chapter. Work in our laboratory is supported by the Post-Doctoral Fellowship, PF-12-151-01-DMC, from the American Cancer Society (CMF), the Ikaria Advancing Newborn Medicine Grant (KTL), American Medical Association Foundation SEED Grant (KTL), 5 T32HD7466-15 (KTL), RO1 HL090136, U01 HL100402 RFA-HL-09-004, American Cancer Society Research Scholar Grant RSG-08-082-01-MGO, the V Foundation for Cancer Research, a Basil O’Conner March of Dimes Starter Award, and the Harvard Stem Cell Institute (CFK).

Keywords

Cell-based therapy
Embryonic stem cells
IPS cells
Lung cancer
Lung cancer stem cells
Lung stem cells
Mesenchymal stromal cells

ASJC Scopus subject areas

Developmental Biology
Cell Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-12-416022-4.00008-1

Cite this

@inbook{b9f9989a31fb40c388924854d6d59e61,

title = "Lung Stem and Progenitor Cells in Tissue Homeostasis and Disease",

abstract = "The mammalian lung is a complex organ containing numerous putative stem/progenitor cell populations that contribute to region-specific tissue homeostasis and repair. In this review, we discuss recent advances in identifying and studying these cell populations in the context of lung homeostasis and disease. Genetically engineered mice now allow for lineage tracing of several lung stem and progenitor cell populations in vivo during different types of lung injury repair. Using specific sets of cell surface markers, these cells can also be isolated from murine and human lung and tested in 3D culture systems and in vivo transplant assays. The pathology of devastating lung diseases, including lung cancers, is likely in part due to dysregulation and dysfunction of lung stem cells. More precise characterization of stem cells with identification of new, unique markers; improvement in isolation and transplant techniques; and further development of functional assays will ultimately lead to new therapies for a host of human lung diseases. In particular, lung cancer biology may be greatly informed by findings in normal lung stem cell biology as evidence suggests that lung cancer is a disease that begins in, and may be driven by, neoplastic lung stem cells.",

keywords = "Cell-based therapy, Embryonic stem cells, IPS cells, Lung cancer, Lung cancer stem cells, Lung stem cells, Mesenchymal stromal cells",

author = "Leeman, {Kristen T.} and Fillmore, {Christine M.} and Kim, {Carla F.}",

note = "Funding Information: We thank members of our laboratory for their discussions and critical comments on the chapter. Work in our laboratory is supported by the Post-Doctoral Fellowship, PF-12-151-01-DMC, from the American Cancer Society (CMF), the Ikaria Advancing Newborn Medicine Grant (KTL), American Medical Association Foundation SEED Grant (KTL), 5 T32HD7466-15 (KTL), RO1 HL090136, U01 HL100402 RFA-HL-09-004, American Cancer Society Research Scholar Grant RSG-08-082-01-MGO, the V Foundation for Cancer Research, a Basil O{\textquoteright}Conner March of Dimes Starter Award, and the Harvard Stem Cell Institute (CFK).",

year = "2014",

doi = "10.1016/B978-0-12-416022-4.00008-1",

language = "English",

series = "Current Topics in Developmental Biology",

pages = "207--233",

booktitle = "Current Topics in Developmental Biology",

}

TY - CHAP

T1 - Lung Stem and Progenitor Cells in Tissue Homeostasis and Disease

AU - Leeman, Kristen T.

AU - Fillmore, Christine M.

AU - Kim, Carla F.

N1 - Funding Information: We thank members of our laboratory for their discussions and critical comments on the chapter. Work in our laboratory is supported by the Post-Doctoral Fellowship, PF-12-151-01-DMC, from the American Cancer Society (CMF), the Ikaria Advancing Newborn Medicine Grant (KTL), American Medical Association Foundation SEED Grant (KTL), 5 T32HD7466-15 (KTL), RO1 HL090136, U01 HL100402 RFA-HL-09-004, American Cancer Society Research Scholar Grant RSG-08-082-01-MGO, the V Foundation for Cancer Research, a Basil O’Conner March of Dimes Starter Award, and the Harvard Stem Cell Institute (CFK).

PY - 2014

Y1 - 2014

N2 - The mammalian lung is a complex organ containing numerous putative stem/progenitor cell populations that contribute to region-specific tissue homeostasis and repair. In this review, we discuss recent advances in identifying and studying these cell populations in the context of lung homeostasis and disease. Genetically engineered mice now allow for lineage tracing of several lung stem and progenitor cell populations in vivo during different types of lung injury repair. Using specific sets of cell surface markers, these cells can also be isolated from murine and human lung and tested in 3D culture systems and in vivo transplant assays. The pathology of devastating lung diseases, including lung cancers, is likely in part due to dysregulation and dysfunction of lung stem cells. More precise characterization of stem cells with identification of new, unique markers; improvement in isolation and transplant techniques; and further development of functional assays will ultimately lead to new therapies for a host of human lung diseases. In particular, lung cancer biology may be greatly informed by findings in normal lung stem cell biology as evidence suggests that lung cancer is a disease that begins in, and may be driven by, neoplastic lung stem cells.

AB - The mammalian lung is a complex organ containing numerous putative stem/progenitor cell populations that contribute to region-specific tissue homeostasis and repair. In this review, we discuss recent advances in identifying and studying these cell populations in the context of lung homeostasis and disease. Genetically engineered mice now allow for lineage tracing of several lung stem and progenitor cell populations in vivo during different types of lung injury repair. Using specific sets of cell surface markers, these cells can also be isolated from murine and human lung and tested in 3D culture systems and in vivo transplant assays. The pathology of devastating lung diseases, including lung cancers, is likely in part due to dysregulation and dysfunction of lung stem cells. More precise characterization of stem cells with identification of new, unique markers; improvement in isolation and transplant techniques; and further development of functional assays will ultimately lead to new therapies for a host of human lung diseases. In particular, lung cancer biology may be greatly informed by findings in normal lung stem cell biology as evidence suggests that lung cancer is a disease that begins in, and may be driven by, neoplastic lung stem cells.

KW - Cell-based therapy

KW - Embryonic stem cells

KW - IPS cells

KW - Lung cancer

KW - Lung cancer stem cells

KW - Lung stem cells

KW - Mesenchymal stromal cells

UR - http://www.scopus.com/inward/record.url?scp=84892475171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892475171&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-416022-4.00008-1

DO - 10.1016/B978-0-12-416022-4.00008-1

M3 - Chapter

C2 - 24439808

AN - SCOPUS:84892475171

T3 - Current Topics in Developmental Biology

SP - 207

EP - 233

BT - Current Topics in Developmental Biology

ER -

Lung Stem and Progenitor Cells in Tissue Homeostasis and Disease

Abstract

Publication series

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this